Skip to content

Mesa Laboratories MLAB Enterprise value

Enterprise value at other companies

3M logo
3MMMM
$83.62B-2.5%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
STERIS logo
STERISSTE
$23.33B-4.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$11.37B+8.5%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Calculated from Mesa Laboratories’s reported figures.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's enterprise value?
Mesa Laboratories (MLAB) reported enterprise value of $540.28M in Q1 2026.
How has Mesa Laboratories's enterprise value changed year-over-year?
Mesa Laboratories's enterprise value decreased by 31.2% year-over-year, from $785.15M to $540.28M.
What is the long-term trend for Mesa Laboratories's enterprise value?
Over 2 years (2024 to 2026), Mesa Laboratories's enterprise value has grown at a -2.3% compound annual growth rate (CAGR), from $566.55M to $540.28M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.